Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 13/20 | 0.49 |
| ▸ | KIT | P10721 | 1/20 | 0.47 |
| ▸ | RAF1 | P04049 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 6/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.47 |
| ▸ | FLT1 | P17948 | 2/20 | 0.47 |
| ▸ | FLT4 | P35916 | 2/20 | 0.47 |
| ▸ | RET | P07949 | 1/20 | 0.47 |
| ▸ | KIF5B | P33176 | 1/20 | 0.47 |
| ▸ | MET | P08581 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15520452 | 0.91 | KDR (0.45) | EGFRKITKDRFLT1RET | |
| SCHEMBL407662 | 0.91 | MET (0.57) | MET | |
| SCHEMBL3836016 | 0.87 | MET (0.43) | EGFRKITRAF1KDRMET | |
| SCHEMBL4458364 | 0.85 | MET (0.53) | EGFRKITRAF1KDRFGFR1 | |
| SCHEMBL3830884 | 0.82 | MET (0.44) | EGFRKDRMET | |
| SCHEMBL3830213 | 0.82 | MET (0.47) | KDRMET | |
| SCHEMBL3829110 | 0.80 | MET (0.47) | KDRMET | |
| SCHEMBL2328218 | 0.80 | MET (0.54) | EGFRKITKDRMET | |
| SCHEMBL371982 | 0.79 | MET (0.58) | EGFRRAF1KDRMET | |
| SCHEMBL2330029 | 0.79 | MET (0.56) | MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2101759-A1 | METHODS OF USING MEK INHIBITORS | Exelixis, Inc. (US) | 2009-09-23 | — | — | EP | claimed |
| WO-2008076415-A1 | METHODS OF USING MEK INHIBITORS | EXELIXIS, INC. (US) | 2008-06-26 | — | — | WO | claimed |